Table 4.
Volume Range (1–120) Allocated Into Areas of Effect Quality (Beneficial, No, and Adverse) for Each Sex and Age Group Individually
| Women | Men | ||||||
|---|---|---|---|---|---|---|---|
| OR<1 | OR=1 | OR>1 | OR<1 | OR=1 | OR>1 | ||
| (Positive) | (No) | (Negative) | (Positive) | (No) | (Negative) | ||
| Age group, y | 50–64 | 1–120 | ··· | ··· | 1–97 | 98–103 | >103 |
| 65–69 | 1–120 | ··· | ··· | 1–96 | 96–101 | >102 | |
| 70–74 | >40 | 1–40 | ··· | 1–94 | 95–100 | >100 | |
| 75–79 | >68 | 7–68 | 1–6 | 1–93 | 94–98 | >98 | |
| 80–90 | >94 | 44–94 | 1–43 | 1–89 | 90–97 | >97 | |
Cutting points were calculated on the basis of Figure 3, particularly the cut points of the 95% CIs and the OR=1.0 line. OR indicates odds ratio.